312 related articles for article (PubMed ID: 19919110)
1. Dual-modality molecular imaging using antibodies labeled with activatable fluorescence and a radionuclide for specific and quantitative targeted cancer detection.
Ogawa M; Regino CA; Seidel J; Green MV; Xi W; Williams M; Kosaka N; Choyke PL; Kobayashi H
Bioconjug Chem; 2009 Nov; 20(11):2177-84. PubMed ID: 19919110
[TBL] [Abstract][Full Text] [Related]
2. In vivo breast cancer characterization imaging using two monoclonal antibodies activatably labeled with near infrared fluorophores.
Sano K; Mitsunaga M; Nakajima T; Choyke PL; Kobayashi H
Breast Cancer Res; 2012; 14(2):R61. PubMed ID: 22510481
[TBL] [Abstract][Full Text] [Related]
3. In vivo molecular imaging of cancer with a quenching near-infrared fluorescent probe using conjugates of monoclonal antibodies and indocyanine green.
Ogawa M; Kosaka N; Choyke PL; Kobayashi H
Cancer Res; 2009 Feb; 69(4):1268-72. PubMed ID: 19176373
[TBL] [Abstract][Full Text] [Related]
4. Fluorescence lifetime imaging of activatable target specific molecular probes.
Alford R; Ogawa M; Hassan M; Gandjbakhche AH; Choyke PL; Kobayashi H
Contrast Media Mol Imaging; 2010; 5(1):1-8. PubMed ID: 20101762
[TBL] [Abstract][Full Text] [Related]
5. Fluorophore-quencher based activatable targeted optical probes for detecting in vivo cancer metastases.
Ogawa M; Kosaka N; Longmire MR; Urano Y; Choyke PL; Kobayashi H
Mol Pharm; 2009; 6(2):386-95. PubMed ID: 19718793
[TBL] [Abstract][Full Text] [Related]
6. In vivo diagnosis of epidermal growth factor receptor expression using molecular imaging with a cocktail of optically labeled monoclonal antibodies.
Barrett T; Koyama Y; Hama Y; Ravizzini G; Shin IS; Jang BS; Paik CH; Urano Y; Choyke PL; Kobayashi H
Clin Cancer Res; 2007 Nov; 13(22 Pt 1):6639-48. PubMed ID: 17982120
[TBL] [Abstract][Full Text] [Related]
7. High sensitivity detection of cancer in vivo using a dual-controlled activation fluorescent imaging probe based on H-dimer formation and pH activation.
Ogawa M; Kosaka N; Regino CA; Mitsunaga M; Choyke PL; Kobayashi H
Mol Biosyst; 2010 May; 6(5):888-93. PubMed ID: 20567775
[TBL] [Abstract][Full Text] [Related]
8. Orthotopic pleural mesothelioma in mice: SPECT/CT and MR imaging with HER1- and HER2-targeted radiolabeled antibodies.
Nayak TK; Bernardo M; Milenic DE; Choyke PL; Brechbiel MW
Radiology; 2013 Apr; 267(1):173-82. PubMed ID: 23329660
[TBL] [Abstract][Full Text] [Related]
9. Tumor-specific detection of an optically targeted antibody combined with a quencher-conjugated neutravidin "quencher-chaser": a dual "quench and chase" strategy to improve target to nontarget ratios for molecular imaging of cancer.
Ogawa M; Kosaka N; Choyke PL; Kobayashi H
Bioconjug Chem; 2009 Jan; 20(1):147-54. PubMed ID: 19072537
[TBL] [Abstract][Full Text] [Related]
10. Short PEG-linkers improve the performance of targeted, activatable monoclonal antibody-indocyanine green optical imaging probes.
Sano K; Nakajima T; Miyazaki K; Ohuchi Y; Ikegami T; Choyke PL; Kobayashi H
Bioconjug Chem; 2013 May; 24(5):811-6. PubMed ID: 23600922
[TBL] [Abstract][Full Text] [Related]
11. In vivo molecular imaging to diagnose and subtype tumors through receptor-targeted optically labeled monoclonal antibodies.
Koyama Y; Barrett T; Hama Y; Ravizzini G; Choyke PL; Kobayashi H
Neoplasia; 2007 Dec; 9(12):1021-9. PubMed ID: 18084609
[TBL] [Abstract][Full Text] [Related]
12. Effect of charge localization on the in vivo optical imaging properties of near-infrared cyanine dye/monoclonal antibody conjugates.
Sato K; Gorka AP; Nagaya T; Michie MS; Nakamura Y; Nani RR; Coble VL; Vasalatiy OV; Swenson RE; Choyke PL; Schnermann MJ; Kobayashi H
Mol Biosyst; 2016 Oct; 12(10):3046-56. PubMed ID: 27452807
[TBL] [Abstract][Full Text] [Related]
13. In vitro and in vivo analysis of indocyanine green-labeled panitumumab for optical imaging-a cautionary tale.
Zhou Y; Kim YS; Milenic DE; Baidoo KE; Brechbiel MW
Bioconjug Chem; 2014 Oct; 25(10):1801-10. PubMed ID: 25243604
[TBL] [Abstract][Full Text] [Related]
14. Dual-labeled trastuzumab-based imaging agent for the detection of human epidermal growth factor receptor 2 overexpression in breast cancer.
Sampath L; Kwon S; Ke S; Wang W; Schiff R; Mawad ME; Sevick-Muraca EM
J Nucl Med; 2007 Sep; 48(9):1501-10. PubMed ID: 17785729
[TBL] [Abstract][Full Text] [Related]
15. Role of Fluorophore Charge on the In Vivo Optical Imaging Properties of Near-Infrared Cyanine Dye/Monoclonal Antibody Conjugates.
Sato K; Gorka AP; Nagaya T; Michie MS; Nani RR; Nakamura Y; Coble VL; Vasalatiy OV; Swenson RE; Choyke PL; Schnermann MJ; Kobayashi H
Bioconjug Chem; 2016 Feb; 27(2):404-13. PubMed ID: 26444497
[TBL] [Abstract][Full Text] [Related]
16. Targeting HER2: a report on the in vitro and in vivo pre-clinical data supporting trastuzumab as a radioimmunoconjugate for clinical trials.
Milenic DE; Wong KJ; Baidoo KE; Nayak TK; Regino CA; Garmestani K; Brechbiel MW
MAbs; 2010; 2(5):550-64. PubMed ID: 20716957
[TBL] [Abstract][Full Text] [Related]
17. Intraoperative near-infrared fluorescence tumor imaging with vascular endothelial growth factor and human epidermal growth factor receptor 2 targeting antibodies.
Terwisscha van Scheltinga AG; van Dam GM; Nagengast WB; Ntziachristos V; Hollema H; Herek JL; Schröder CP; Kosterink JG; Lub-de Hoog MN; de Vries EG
J Nucl Med; 2011 Nov; 52(11):1778-85. PubMed ID: 21990576
[TBL] [Abstract][Full Text] [Related]
18. Target-cancer-cell-specific activatable fluorescence imaging probes: rational design and in vivo applications.
Kobayashi H; Choyke PL
Acc Chem Res; 2011 Feb; 44(2):83-90. PubMed ID: 21062101
[TBL] [Abstract][Full Text] [Related]
19.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
20.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
[Next] [New Search]
